差分

621 バイト追加、 2021年4月26日 (月) 11:17

編集の要約なし

===weakness of MA===

==conduct SR/MA==

*no guidelines on the number of included studies in SR/MA

*Cochrane has published SR/MA with only 1 study included

===optimal databases===

Bramer WM, et al. Syst Rev. 2017 PMID:29208034

*Medline/PubMed

*Web of Science

*Embase and/or Scopus

**overlapping ratio between Embase and Scopus is very high

*Google Scholar

**grey literature

as many as possible

*grey literatures

**Google Scholar

**New York Academy of Medicine Grey Literature Report

**[[https://en.wikipedia.org/wiki/System_for_Information_on_Grey_Literature_in_Europe SIGLE]]

===data extraction===

*most important and easily mistaken step

2,992

回編集

Systematic review and Meta-analysis (ソースを閲覧)